Home - Products - Tyrosine Kinase - c-RET - 4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylic acid

4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylic acid

CAS No. 144059-86-9

4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylic acid( —— )

Catalog No. M18018 CAS No. 144059-86-9

4-Methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylic acid is a metabolite of GW 501516.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 29 In Stock
25MG 48 In Stock
50MG 69 In Stock
100MG 103 In Stock
200MG 155 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylic acid is a metabolite of GW 501516.
  • Description
    4-Methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylic acid is a metabolite of GW 501516.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    c-RET
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    144059-86-9
  • Formula Weight
    287.26
  • Molecular Formula
    C12H8F3NO2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=C(SC(=N1)C2=CC=C(C=C2)C(F)(F)F)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Enbezotinib

    Enbezotinib is an inhibitor of RET autophosphorylation and can be used in cancer research.

  • Pralsetinib

    Pralsetinib (BLU-667) is a highly potent, selective RET inhibitor (IC50s: 0.4, 0.3, 0.4, 0.4, and 0.4 nM for WT RET, RET mutants V804L, V804M, M918T and CCDC6-RET fusion).

  • Vepafestinib

    Vepafestinib is a RET inhibitor with potential antineoplastic activity.